Ellevest’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$297K Buy
1,276
+59
+5% +$13.6K 0.03% 342
2026
Q2
$257K Buy
+1,217
New +$239K 0.03% 389
2022
Q3
– Sell
-41
Closed -$5K – 1666
2022
Q2
$5K Hold
41
– – ﹤0.01% 1004
2022
Q1
$6K Buy
+41
New +$5.72K ﹤0.01% 974
2021
Q3
– Sell
-9
Closed -$1K – 1443
2021
Q2
$1K Sell
9
-320
-97% -$41.9K ﹤0.01% 1137
2021
Q1
$42K Hold
329
– – 0.01% 514
2020
Q4
$39K Sell
329
-275
-46% -$33.5K 0.01% 513
2020
Q3
$69K Sell
604
-14
-2% -$1.65K 0.01% 323
2020
Q2
$70K Buy
618
+88
+17% +$9.33K 0.02% 303
2020
Q1
$43K Buy
530
+45
+9% +$4.66K 0.01% 258
2019
Q4
$52K Buy
485
+480
+9,600% +$50.1K 0.01% 183
2019
Q3
$1K Buy
+5
New +$513 ﹤0.01% 382

Other funds holding DGX

Ellevest's DGX Position: Q3 2026 in Review

Ellevest increased its Quest Diagnostics (DGX) stake by 4.8% in Q3 2026, buying an estimated $13.6K and bringing the position to 1,276 shares worth $297K. The position accounts for 0.03% of the portfolio, ranked #342.

Ellevest first reported a position in DGX in Q3 2019 and has held it in 12 quarters since. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Ellevest held 1,276 shares of Quest Diagnostics worth $297K as of Q3 2026.
  • Ellevest bought 59 Quest Diagnostics shares in Q3 2026, an estimated $13.6K.
  • Quest Diagnostics made up 0.03% of Ellevest's portfolio in Q3 2026, its #342 holding.
  • Ellevest first reported a position in Quest Diagnostics in Q3 2019 and has held it in 12 quarters since.
  • 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.